1-6 of 6
Andrew E. Place
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT112: A Phase I multicenter trial of the dual MDM2/MDMX inhibitor ALRN-6924 in children and young adults with relapsed/refractory pediatric cancers

David S. Shulman, Kieuhoa T. Vo, Elizabeth Fox, Jodi A. Muscal, Loren D. Walensky, Yana Pikman, Kimberly Stegmaier, Alanna Church, Brian D. Crompton, Andrew E. Place, Susan N. Chi, Allison F. O'Neill, Junne Kamihara, Suzanne Ezrre, Cecilia Carlowicz, Dawn Pinchasik, Hasan Al-Sayegh, Clement Ma, Wendy B. London, Steven G. DuBois
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT112.
https://doi.org/10.1158/1538-7445.AM2019-CT112
Published: 01 July 2019
View article titled, Abstract CT112: A Phase I multicenter trial of the dual MDM2/MDMX inhibitor ALRN-6924 in children and young adults with relapsed/refractory pediatric cancers
Journal Articles

Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes

Andriy Marusyk, Doris P. Tabassum, Michalina Janiszewska, Andrew E. Place, Anne Trinh, Andrii I. Rozhok, Saumyadipta Pyne, Jennifer L. Guerriero, Shaokun Shu, Muhammad Ekram, Alexander Ishkin, Daniel P. Cahill, Yuri Nikolsky, Timothy A. Chan, Mothaffar F. Rimawi, Susan Hilsenbeck, Rachel Schiff, Kent C. Osborne, Antony Letai, Kornelia Polyak
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (22): 6495–6506.
https://doi.org/10.1158/0008-5472.CAN-16-1457
Published: 14 November 2016
View article titled, Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes
Open the PDF for Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes in another window
Includes: Supplementary data
Journal Articles

The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling

Karen Liby, Thomas Hock, Mark M. Yore, Nanjoo Suh, Andrew E. Place, Renee Risingsong, Charlotte R. Williams, Darlene B. Royce, Tadashi Honda, Yukiko Honda, Gordon W. Gribble, Nathalie Hill-Kapturczak, Anupam Agarwal, Michael B. Sporn
Journal: Cancer Research
Cancer Res (2005) 65 (11): 4789–4798.
https://doi.org/10.1158/0008-5472.CAN-04-4539
Published: 01 June 2005
View article titled, The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling
Open the PDF for The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling in another window
Journal Articles

The synthetic triterpenoid, CDDO-Imidazolide, activates heme oxygenase-1 and other Nrf2-responsive genes in human leukemia cells

Karen Liby, Andrew E. Place, Nanjoo Suh, Renee Risingsong, Charlotte Williams, Nathalie Hill-Kapturczak, Anupam Agarwal, Tadashi Honda, Gordon Gribble, Michael B. Sporn
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 318.
Published: 01 April 2004
View article titled, The synthetic triterpenoid, CDDO-Imidazolide, activates heme oxygenase-1 and other Nrf2-responsive genes in human leukemia cells
Journal Articles

Synthetic Triterpenoids Enhance Transforming Growth Factor β/Smad Signaling

Nanjoo Suh, Anita B. Roberts, Stephanie Birkey Reffey, Kohei Miyazono, Susumu Itoh, Peter ten Dijke, Elke H. Heiss, Andrew E. Place, Renee Risingsong, Charlotte R. Williams, Tadashi Honda, Gordon W. Gribble, Michael B. Sporn
Journal: Cancer Research
Cancer Res (2003) 63 (6): 1371–1376.
Published: 15 March 2003
View article titled, Synthetic Triterpenoids Enhance Transforming Growth Factor β/Smad Signaling
Open the PDF for Synthetic Triterpenoids Enhance Transforming Growth Factor β/Smad Signaling in another window
Journal Articles

A Novel Synthetic Oleanane Triterpenoid, 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid, with Potent Differentiating, Antiproliferative, and Anti-Inflammatory Activity

Nanjoo Suh, Yongping Wang, Tadashi Honda, Gordon W. Gribble, Ethan Dmitrovsky, William F. Hickey, Robert A. Maue, Andrew E. Place, Donna M. Porter, Michael J. Spinella, Charlotte R. Williams, Gengfei Wu, Andrew J. Dannenberg, Kathleen C. Flanders, John J. Letterio, David J. Mangelsdorf, Carl F. Nathan, Lananh Nguyen, Weston W. Porter, Renee F. Ren, Anita B. Roberts, Nanette S. Roche, Kotha Subbaramaiah, Michael B. Sporn
Journal: Cancer Research
Cancer Res (1999) 59 (2): 336–341.
Published: 15 January 1999
View article titled, A Novel Synthetic Oleanane Triterpenoid, 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid, with Potent Differentiating, Antiproliferative, and Anti-Inflammatory Activity
Open the PDF for A Novel Synthetic Oleanane Triterpenoid, 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid, with Potent Differentiating, Antiproliferative, and Anti-Inflammatory Activity in another window